Amrutanjan Health Care Limited

Web: amrutanjan.com NSE: AMRUTANJAN BSE: 590006 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

500 4(1%)

Near 52W Low of 476

Volume

19k as on 18, Sep

Open

744

High

744

Low

727

496

VWAP

493

52 Week High

791

52 Week Low

476

Viand Research Rating

Quality Score

33/100

Growth Score

29/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,446

No. of Shares

2.89

P/E

44.29

P/B

7.3

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

16.47

ROCE

Profit Growth

Listing Date

02-Jan-15

Rank/Sector Rank

#1036/-

Promoter Holding

46.52%

FII Holding

2.44%

DII Holding

12.29%

Price Chart

Price Performance

1 Week1%

1 Month1%

3 Months10%

6 Months5%

1 Year11%

YTD11%

Moving Average

5 Day SMA491

10 Day SMA496

20 Day SMA506

30 Day SMA506

50 Day SMA514

61 Day SMA519

80 Day SMA527

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	499	492	496	498
Resistance 2	496	492	494	496
Resistance 1	494	491	493	493
Pivot Point	491	491	491	490
Support 1	488	491	489	488
Support 2	485	490	488	485
Support 3	483	490	485	482

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,43,003	1866	1%	3%	4%	13%	37	57.7	0.07	11509
2	DIVISLAB	2,48,266	9352	2%	9%	53%	55%	69	57.7	0	2568
3	TORNTPHARM	1,87,707	4935	2%	1%	16%	35%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,041	9025	1%	2%	20%	15%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,15,940	1162	6%	4%	31%	11%	20	57.7	0.31	3560
6	CIPLA	1,11,816	1379	2%	3%	10%	9%	22	57.7	0.02	3862
7	LAURUSLABS	1,08,414	2006	4%	11%	103%	120%	0	57.7	0.48	890
8	MAXHEALTH	1,02,830	1066	3%	6%	10%	9%	0	57.7	0.32	1442
9	MANKIND	1,02,435	2480	9%	4%	24%	3%	49	57.7	0.39	1938
10	DRREDDY	1,01,077	1216	2%	1%	8%	10%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(-4.11) 46.52%	(0.01) 50.58%	(0.01) 50.59%	(0.01) 50.59%	(0.61) 50.59%	(0.01) 50.03%	(0.01) 50.03%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%
FIIs	(0.31) 2.44%	(-0.11) 2.17%	(-0.11) 2.27%	(0.01) 2.38%	(0.11) 2.41%	(0.01) 2.30%	(0.01) 2.30%	(0.81) 2.34%	(0.21) 1.55%	(0.61) 1.38%	(0.11) 0.80%	(0.11) 0.75%	(0.01) 0.69%	(-0.11) 0.68%	(-0.11) 0.76%	(-0.61) 0.87%	(0.01) 1.42%	(-0.41) 1.43%	(0.31) 1.83%	(0.01) 1.53%
DIIs	(-0.41) 12.29%	(-0.31) 12.66%	(0.11) 13.00%	(0.21) 12.90%	(1.31) 12.70%	(0.31) 11.41%	(0.51) 11.13%	(3.31) 10.60%	(0.01) 7.32%	(0.01) 7.29%	(0.11) 7.24%	(-0.11) 7.10%	(0.01) 7.22%	(0.81) 7.18%	(0.11) 6.39%	(0.11) 6.30%	(0.01) 6.16%	(0.01) 6.14%	(-0.81) 6.14%	(0.01) 6.94%
Public	38.72%	38.61%	38.18%	38.16%	38.34%	39.75%	40.01%	40.50%	40.47%	40.66%	41.19%	41.39%	41.87%	41.93%	42.65%	42.62%	42.21%	42.23%	41.90%	41.41%
No. of Shareholders	45,135	45,805	46,675	47,954	49,431	51,674	53,856	54,536	57,169	62,664	68,404	72,002	71,428	69,947	72,104	71,064	66,173	67,323	61,367	41,640

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	102.97	149.77	141.04	117.7	94.05	135.41	122.75	109.92	83.74	127.06	116.99	99.31	77.86
Sales Growth % (YoY)	9.5%	10.6%	14.9%	7.1%	12.3%	6.6%	4.9%	10.7%	7.6%	26.6%	19.8%	-10.3%	9.7%
Sales Growth % (QoQ)	-31.2%	6.2%	19.8%	25.1%	-30.5%	10.3%	11.7%	31.3%	-34.1%	8.6%	17.8%	27.5%	-
Expenses	96.73	124.22	115.87	101.18	85.61	117.71	99.4	96.32	80.19	110.82	95.42	92.47	70.71
Operating Profit	6.24	25.55	25.17	16.52	8.44	17.7	23.35	13.6	3.55	16.24	21.57	6.84	7.15
OPM %	6.06	17.06	17.85	14.04	8.97	13.07	19.02	12.37	4.24	12.78	18.44	6.89	9.18
Other Income	1.78	-2.88	2.87	4.3	4.43	4.82	4.36	4.05	4.45	4.95	3.76	3.95	3.69
Interest	0.04	0.05	0.05	0.05	0.05	0.04	0.06	0.06	0.06	0.05	0.05	0.03	0.02
Depreciation	1.92	1.61	1.62	1.56	1.53	1.62	1.66	1.65	1.59	1.53	1.58	1.55	1.39
Profit before tax	6.06	21.01	26.37	19.21	11.29	20.86	25.99	15.94	6.35	19.61	23.7	9.21	9.43
Tax %	28.05	22.94	26.2	27.33	26.4	27.23	25.93	25.97	27.24	30.34	26.41	25.62	25.56
Net Profit	4.37	16.19	19.45	13.96	8.31	15.18	19.25	11.8	4.62	13.66	17.45	6.85	7.01
Net Profit Growth % (QoQ)	-73%	-16.8%	39.3%	68%	-45.3%	-21.1%	63.1%	155.4%	-66.2%	-21.7%	154.7%	-2.3%	-
Net Profit Growth % (YoY)	-47.4%	6.7%	1%	18.3%	79.9%	11.1%	10.3%	72.3%	-34.1%	-	-	-	-
TTM Net Profit	53.97	57.91	56.9	56.7	54.54	50.85	49.33	47.53	42.58	44.97	31.31	13.86	0
EPS in Rs	1.51	5.6	6.73	4.83	2.87	5.25	6.66	4.08	1.6	4.72	6.04	2.37	2.4

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Sales	503	452	421	380	406	333	261	253	220	207	174	154	134	131	136	101	86	87	71	69	67
Sales Growth %	11.2%	7.3%	11%	-6.5%	21.9%	27.3%	3.3%	15.1%	6.3%	18.6%	12.9%	17.5%	2.8%	-4.2%	35.1%	17.3%	-1.1%	22.4%	3.4%	3.3%	-
Expenses	427	394	369	335	326	258	231	222	192	178	143	130	112	113	118	88	76	182	60	53	53
Operating Profit	76	58	52	45	80	75	31	31	28	29	32	25	22	17	18	13	10	-95	11	16	13
OPM %	15	13	12	12	20	22	12	12	13	14	18	16	16	13	13	13	12	-109	16	23	20
Other Income	9	18	16	15	15	11	8	7	8	7	6	5	3	4	4	5	10	220	0	-2	1
Interest	0	0	0	0	1	1	0	0	0	0	0	1	2	2	3	1	0	0	1	1	1
Depreciation	6	7	6	5	4	4	4	3	3	2	3	2	4	4	3	2	1	2	2	2	3
Profit before tax	78	69	62	54	91	82	34	35	33	34	35	26	19	15	16	15	19	123	9	11	11
Tax %	26	26	27	26	26	25	27	29	39	35	35	35	36	35	39	34	38	25	42	46	45
Net Profit	58	51	45	40	67	61	25	25	20	22	22	17	12	10	10	10	11	92	5	6	6
Net Profit Growth %	13.7%	13.3%	12.5%	-40.3%	9.8%	144%	-	25%	-9.1%	-	29.4%	41.7%	20%	-	-	-9.1%	-88%	1740%	-16.7%	-	-
EPS in Rs	20.03	17.58	15.55	13.63	22.99	20.93	8.58	8.39	6.84	7.47	7.68	5.86	4.26	3.47	3.32	0	0	29.8	0	0	0
Dividend Payout %	24	26	30	34	20	20	24	26	22	26	25	30	38	43	45	45	40	19	45	32	22

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Cash from Operating Activity	36	51	28	20	52	91	18	21	19	8	21	19	17	9	4	6	11	6	5	11	10
Cash from Investing Activity	-21	-31	19	-2	-36	-88	-14	-11	-8	0	1	-5	16	13	14	-29	-47	89	-8	-4	3
Cash from Financing Activity	-14	-13	-48	-15	-17	-7	-12	-7	-9	-5	-11	-12	-14	-14	-27	20	-8	-30	-2	-1	-12
Net Cash Flow	1	6	-1	3	-1	-4	-7	3	2	3	12	2	20	8	-9	-4	-43	65	-5	6	1

Balance Sheet

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Equity Capital	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3
Reserves	367	324	286	288	262	213	156	143	126	113	118	102	86	79	74	98	94	90	23	20	15
Borrowings	2	2	2	1	1	1	2	0	0	2	0	0	8	15	22	30	1	1	8	8	6
Other Liabilities	137	93	77	70	84	57	44	42	38	34	28	25	23	27	25	26	20	17	14	10	13
Total Liabilities	509	421	367	362	350	274	205	188	166	152	149	130	120	124	124	157	118	111	48	41	37
Fixed Assets	51	49	50	49	28	23	26	26	28	27	22	13	27	30	33	52	16	16	20	13	16
CWIP	106	16	2	1	17	2	0	0	0	1	1	4	1	1	1	0	7	2	3	3	0
Investments	3	0	0	5	13	18	18	18	8	10	10	14	9	25	29	42	46	0	0	0	0
Other Assets	349	356	315	307	291	232	161	144	131	115	116	100	83	69	62	62	50	92	25	26	21
Total Assets	509	421	367	362	350	274	205	188	166	152	149	130	120	124	124	157	118	111	48	41	37

Delivery

Delivery Data: AMRUTANJAN

#	Date	476 16% 552	Value (Cr)	Q/T 47	Del 65	Del 15
1	22-Sep	500	2	14	58	1
2	21-Sep	496	1	14	58	1
3	18-Sep	494	1	15	53	0
4	17-Sep	491	1	16	69	0
5	16-Sep	490	3	22	57	2
6	15-Sep	490	1	20	58	1
7	11-Sep	491	4	16	59	2
8	10-Sep	493	3	15	56	1
9	9-Sep	504	4	20	59	2
10	8-Sep	500	2	19	58	1
11	7-Sep	500	3	24	51	2
12	4-Sep	505	2	40	47	1
13	3-Sep	507	3	51	75	3
14	2-Sep	500	2	11	54	1
15	1-Sep	498	3	16	54	1
16	31-Aug	509	4	14	56	2
17	28-Aug	514	3	15	50	2
18	27-Aug	517	5	19	51	2
19	26-Aug	528	2	23	66	1
20	25-Aug	523	7	31	61	4
21	24-Aug	522	3	19	45	1
22	21-Aug	536	33	31	43	14
23	20-Aug	522	75	46	38	29
24	19-Aug	499	2	19	59	1
25	18-Aug	488	3	25	63	2
26	17-Aug	492	3	19	53	1
27	14-Aug	496	2	14	51	1
28	13-Aug	492	5	24	57	3
29	12-Aug	488	27	33	52	14
30	11-Aug	534	3	22	60	2
31	10-Aug	527	3	25	52	2
32	7-Aug	521	2	13	56	1
33	6-Aug	520	1	12	68	1
34	5-Aug	524	2	15	57	1
35	4-Aug	518	1	12	60	1
36	3-Aug	521	0	10	56	0
37	31-Jul	515	4	85	95	4
38	30-Jul	516	1	14	66	1
39	29-Jul	517	1	10	55	0
40	28-Jul	511	1	17	61	1
41	27-Jul	513	3	13	67	2
42	24-Jul	509	3	26	75	3
43	23-Jul	520	2	14	51	1
44	22-Jul	529	2	16	66	1
45	21-Jul	539	1	12	67	1
46	20-Jul	547	3	20	35	1
47	17-Jul	538	1	15	63	1
48	16-Jul	535	1	16	58	1
49	15-Jul	534	2	25	63	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
22-Sep	1,446c	29c	2.04
17-Sep	1,417c	13c	0.90
10-Sep	1,430c	15c	1.06
07-Sep	1,445c	14c	0.97
04-Sep	1,459c	8c	0.51
03-Sep	1,467c	3c	0.21
01-Sep	1,470c	12c	0.84
31-Aug	1,482c	6c	0.41
27-Aug	1,488c	31c	2.06
26-Aug	1,519c	6c	0.36
25-Aug	1,525c	25c	1.69
24-Aug	1,500c	42c	2.73
21-Aug	1,542c	99c	6.85
19-Aug	1,443c	31c	2.16
18-Aug	1,412c	14c	0.98
17-Aug	1,426c	7c	0.46
14-Aug	1,420c	20c	1.39
13-Aug	1,440c	41c	2.89
12-Aug	1,399c	137c	8.90
11-Aug	1,536c	0	0

Stock Checklist

Price is above from 52 week high low average: 7%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 2 fund house(s) as of Sep26 · Total value ₹88 Cr · 4 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	6	0.54%	+0.07%	84.6
DSP Mutual Fund	2	0.01%	-0.20%	3.6

Amrutanjan Health Care Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements